Research reveals widespread use of ineffective COVID-19 treatments after FDA deauthorized their use
Beth Israel Deaconess Medical CenterIn a paper published in JAMA Network Open, physician-scientists assessed the use of these two monoclonal antibodies for patients with COVID-19 before and after FDA deauthorization.